EUVIMEDEUVIMED entdecken
Crossref

L26/P-343 Multi-omics human/microbial atlas of chronic endometritis reveals microbial signatures and host immune responses

A. Sola-Leyva, L. Blanco-Rodríguez, L. Van Wijmeersch, A. Apostolov, A. DS Pathare, W. Waelput, T. Demuyser, M. Saare, R. Mändar, K. Krjutšhkov, S. Mackens, A. Salumets

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Sola-Leyva und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does integrating microbial DNA and RNA sequencing reveal active microbes, disease-specific cell populations, and host transcriptomic responses in chronic endometritis? Summary answer Preliminary analyses suggest limited concordance between DNA- and RNA-detected microorganisms, with RNA-enriched microbes potentially associated with disease presence, severity, and host response. What is known already Chronic endometritis is recognized as a multifactorial condition involving microbial dysbiosis and/or altered immune responses within the endometrium. DNA-based sequencing cannot distinguish transcriptionally active microorganisms from residual or extracellular DNA. RNA-based approaches provide insight into microbial activity and host–microbe interactions, and previous studies have demonstrated their ability to reveal active pathogens in the vagina and endometrium. However, the relevance of RNA-detected microbes in endometritis remains poorly defined. Integrating microbial DNA and RNA profiling with host transcriptomic and cellular architecture is expected to help uncover active pathogenic mechanisms, refine immune-associated signatures, and support the development of molecular biomarkers beyond histopathological criteria. Study design, size, duration In total, sixty-eight women aged 25–45 years were enrolled. Chronic endometritis severity was classified as follows: score 0, no CD138-positive plasma cells (n = 20); score IPC, fewer than five isolated CD138-positive plasma cells (n = 20); score 1, ≥1 cluster of 5–19 plasma cells per 0.25 mm² (n = 20); score 2, ≥1 cluster of 20–49 plasma cells per 0.25 mm² and score 3, ≥1 cluster of 50 or more plasma cells per 0.25 mm² (n = 8). Participants/materials, setting, methods Chronic endometritis was diagnosed by CD138 immunohistochemistry in endometrial biopsies collected using a Pipelle de Cornier, with paired vaginal samples obtained using ESwabs. DNA and RNA were extracted using Qiagen kits and sequenced for microbial profiling. Comprehensive taxonomic, functional, and host transcriptomic analyses are currently ongoing using Kraken2, Bracken, and HUMAnN3. Spatial immune characterization and cellular architecture analyses are in progress using a fluorescent multiplex immunohistochemistry pipeline across endometritis severity stages. Main results and the role of chance Initial observations indicate limited concordance between metagenomic (16S rRNA sequencing) and metatranscriptomic (RNA sequencing) profiles in chronic endometritis. Preliminary findings suggest that a subset of transcriptionally active microorganisms may be preferentially detected at the RNA level, including taxa such as Ureaplasma, Gardnerella, and Mycoplasma. Host transcriptomic and immune-cell–resolved analyses are currently being performed, and their results will be integrated with microbial findings upon completion. Limitations, reasons for caution These findings reflect ongoing analysis. In addition, some participants presented additional gynecological diagnoses alongside chronic endometritis, an unavoidable limitation given that most cases were identified in an IVF clinical setting. Wider implications of the findings Once fully completed, this integrative multi-omics atlas is expected to provide for the first time a comprehensive view of active microbial communities and coordinated host immune responses in chronic endometritis, informing future mechanistic studies and the development of improved diagnostic and molecular stratification approaches. Trial registration number No

Zitieren

APA

Sola-Leyva, A., Blanco-Rodríguez, L., Wijmeersch, L. V., Apostolov, A., Pathare, A. D., Waelput, W., Demuyser, T., Saare, M., Mändar, R., Krjutšhkov, K., Mackens, S., & Salumets, A. (2026). L26/P-343 Multi-omics human/microbial atlas of chronic endometritis reveals microbial signatures and host immune responses. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.679

Vancouver

Sola-Leyva A, Blanco-Rodríguez L, Wijmeersch LV, Apostolov A, Pathare AD, Waelput W, et al. L26/P-343 Multi-omics human/microbial atlas of chronic endometritis reveals microbial signatures and host immune responses. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.679

BibTeX
@article{SolaLeyva2026,
  author = {Sola-Leyva, A. and Blanco-Rodríguez, L. and Wijmeersch, L. Van and Apostolov, A. and Pathare, A. DS and Waelput, W. and Demuyser, T. and Saare, M. and Mändar, R. and Krjutšhkov, K. and Mackens, S. and Salumets, A.},
  title = {L26/P-343 Multi-omics human/microbial atlas of chronic endometritis reveals microbial signatures and host immune responses},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.679}
}
Kostenlos starten →